Department of Ophthalmology, the Second Affiliated Hospital of Fujian Medical University, Fujian Medical University, Fujian Province University Engineering Research Center of Assistive Technology for Visual Impairment, Quanzhou 362000, China
Abstract： Color blindness is a common visual abnormality or deficiency disease that is usually caused by genetic factors. Color blind patients have different degrees of reduced color recognition, which affects their life and work. At present, color blindness optical correction and gene therapy to restore color vision functions need to be verified. And with the development of computer vision science and artificial intelligence, the application of color blindness correction has become a new method. This article summarizes the current treatment and correction methods for color blindness, so that ophthalmologists and computer engineering technicians can have a better understanding of them, which will help to advance the best color blindness correction measures and improve the quality of life of people with color blindness.
Cole BL. The handicap of abnormal colour vision. Clin Exp Optom, 2004, 87: 258-275. DOI: 10.1111/j.1444-0938.2004. tb05056.x.
[3]
Stoianov M, de Oliveira MS, Dos Santos Ribeiro Silva MCL, et al. The impacts of abnormal color vision on people's life: An integrative review. Qual Life Res, 2019, 28(4): 855-862. DOI: 10.1007/s11136-018-2030-1.
Acland GM, Aguirre GD, Ray J, et al. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet, 2001, 28(1): 92-95. DOI: 10.1038/ng0501-92.
Hassall MM, Barnard AR, MacLaren RE. Gene therapy for color blindness. Yale J Biol Med, 2017, 90(4): 543-551.
[12]
Mancuso K, Hauswirth WW, Li Q, et al. Gene therapy for red-green colour blindness in adult primates. Nature, 2009, 461(7265): 784-787. DOI: 10.1038/nature08401.
[13]
Carvalho LS, Xu J, Pearson RA, et al. Long-term and age-dependent restoration of visual function in a mouse model of CNGB3-associated achromatopsia following gene therapy. Hum Mol Genet, 2011, 20(16): 3161-3175. DOI: 10.1093/hmg/ ddr218.
Pang JJ, Alexander J, Lei B, et al. Achromatopsia as a potential candidate for gene therapy. Adv Exp Med Biol, 2010, 664: 639- 646. DOI: 10.1007/978-1-4419-1399-9_73.
[17]
Badawy AR, Hassan MU, Elsherif M, Ahmed Z, Yetisen AK, Butt H. Contact Lenses for Color Blindness. Adv Healthc Mater, 2018, 7(12): e1800152. DOI: 10.1002/adhm.201800152.
Sharpe LT, Jagle H. I Used To Be Color Blind. Color Research and Application, 2001, 26(S1): 269-272.
[21]
Mastey R, Patterson EJ, Summerfelt P, et al. Effect of "colorcorrecting glasses" on chromatic discrimination in subjects with congenital color vision deficiency. Invest Ophthalmol Vis Sci, 2016, 57(12): 121.
[22]
Yang S, Ro YM, Wong EK, et al. Color compensation for anomalous trichromats based on error score of FM-100 Hue test. Conf Proc IEEE Eng Med Biol Soc, 2005, 2005: 6571-6574. DOI: 10.1109/IEMBS.2005.1616006.
[23]
Kim M, Nam J, Ro YM, et al. Visual content adaptation according to user perception characteristics. IEEE transactions on multimedia, 2005, 7(3): 435-445.
[24]
Rasche K, Geist R, Westall J. Detail preserving reproduction of color images for monochromats and dichromats. IEEE Comput Graph Appl, 2005, 25(3): 22-30. DOI: 10.1109/mcg.2005.54.
[25]
Deng YH, Wang YY, Ma Y, et al. A Fixed Transformation of Color Images for Dichromats Based on Similarity Matrices. 3rd International Conference on Intelligent Computing (ICIC 2007). 2007, Qingdao, China. 1018-1028.
[26]
Tumblin J, Gooch AA, Gooch B, et al. Color 2 Gray: Salience-preserving color removal. ACM Trans Graph, 2005, 24(3): 634- 639.
Swihart SL, Matheny A. Classification of chromatic visual evoked potentials with the aid of a neural net. Comput Biol Med, 1992, 22(3): 165-171. DOI: 10.1016/0010-4825(92)90012-c.
Melillo P, Riccio D, Di Perna L, et al. Wearable Improved Vision System for Color Vision Deficiency Correction. IEEE J Transl Eng Health Med, 2017, 5: 3800107. DOI: 10.1109/ JTEHM.2017.2679746.
浙公网安备 33030202001892号